Table 2 Baseline characteristics of CAD and NCAD groups before surgery
| Â | CAD (n = 37) | NCAD (n = 16) | P |
|---|---|---|---|
Age (years) | 59.1 ± 8.0 | 54.3 ± 9.4 | NS |
Male (%) | 30 (81.1) | 12 (75.0) | NS |
Hypertension (%) | 27 (73.0) | 3 (18.8) | < 0.001 |
T2 DM (%) | 11 (29.7) | 1 (6.2) | NS |
BMI (kg/m2) | 27.1 ± 3.4 | 24.3 ± 2.6 | 0.004 |
Waist circumference (cm) | 94.7 ± 9.2 | 85.5 ± 9.8 | 0.002 |
LVEF (%) | 56.2 ± 10.1 | 60.1 ± 8.1 | NS |
Systolic blood pressure (mmHg) | 129.3 ± 20.7 | 127.1 ± 19.5 | NS |
Diastolic blood pressure (mmHg) | 78.1 ± 12.4 | 79 ± 14.0 | NS |
Aspirin (%) | 16 (43.2) | 0 (0) | 0.005 |
Nitrates (%) | 37 (100) | 0 (0) | < 0.001 |
ACEIs/ARBs (%) | 22 (59.5) | 9 (56.2) | NS |
Statins (%) | 25 (67.6) | 0 (0) | < 0.001 |
β-blockers (%) | 35 (94.6) | 3 (18.8) | < 0.001 |
Calcium channel blockers (%) | 13 (35.1) | 0 (0) | 0.017 |
Insulin (%) | 5 (13.5) | 1 (6.2) | NS |
Oral hypoglyceimic agents (%) | 9 (24.3) | 1 (6.2) | NS |
Diuretics (%) | 2 (5.4) | 16 (100) | < 0.001 |
Antibiotics (%) | 6 (16.2) | 4 (25.0) | NS |
Fasting glucose (mmol/L) | 6.08 (5.25, 7.45) | 5.19 (4.86, 5.51) | 0.002 |
HbA1C (%) | 6.3 ± 0.8 | 6.0 ± 0.6 | NS |
Fasting insulin (μU/mL) | 4.67 (2.43, 45.75) | 2.27 (1.77, 3.06) | 0.031 |
HOMA-IR | 1.43 (0.69, 1.32) | 0.53 (0.44, 0.68) | 0.013 |
Total cholesterol (mmol/L) | 4.44 ± 1.00 | 4.83 ± 0.73 | NS |
HDL-C (mmol/L) | 1.07 ± 0.24 | 1.25 ± 0.22 | 0.014 |
LDL-C (mmol/L) | 2.68 ± 0.81 | 2.89 ± 0.53 | NS |
Triglycerides (mmol/L) | 1.88 ± 1.09 | 1.77 ± 1.49 | NS |
Urea nitrogen (mmol/L) | 6.82 ± 2.58 | 7.67 ± 2.46 | NS |
Serum creatinine (μmol/L) | 89.9 ± 21.3 | 83.5 ± 20.1 | NS |
Uric acid (μmol/L) | 380.2 ± 111.1 | 393.3 ± 96.8 | NS |
hsCRP (mg/L) | 1.95 (0.98, 6.75) | 1.07 (0.51, 1.66) | 0.003 |